TherapeuticsMD (TXMD) Preferred Dividend Payments (2012 - 2013)
TherapeuticsMD's (TXMD) quarterly Preferred Dividend Payments came in at $1.1 million in Q2 2013, up 115.7% YoY from $488936.3 in Q2 2012, and up 115.7% on a QoQ basis from -$6.7 million in Q2 2012.
TherapeuticsMD (TXMD) Preferred Dividend Payments (2012 - 2013) Analysis & Trends
TherapeuticsMD (TXMD) has 2 years of Preferred Dividend Payments data on file, last reported at $1.1 million in Q2 2013.
- Quarterly Preferred Dividend Payments rose 115.7% year-over-year to $1.1 million in Q2 2013, while the trailing twelve-month figure through Jun 2013 was -$5.7 million (changed N/A YoY) and the FY2012 annual result came in at -$6.7 million, changed N/A from the prior year.
- Preferred Dividend Payments rose to $1.1 million in Q2 2013, from -$6.7 million in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $1.1 million in Q2 2013 to a low of -$6.7 million in Q2 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | TherapeuticsMD | 23.78 Mn | 14.60 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2013 | 1.05 Mn |
| Jun 30, 2012 | -6.72 Mn |